Common Contracts

AMENDED AND RESTATED CREDIT AGREEMENT

Credit Agreement • June 13th, 2018 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations • New York

• Contract Type
  Credit Agreement
• Filed
  June 13th, 2018
• Company
  Alexion Pharmaceuticals Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This AMENDED AND RESTATED CREDIT AGREEMENT (this “Agreement”) is entered into as of June 7, 2018, among ALEXION PHARMACEUTICALS, INC., a Delaware corporation (the “Administrative Borrower”), ALEXION PHARMA HOLDING UNLIMITED COMPANY (f/k/a Alexion Pharma Holding), a company incorporated in Ireland with company registration number 528477 and having its registered office at 25-28 North Wall Quay, Dublin 1 Ireland (“APH”), ALEXION PHARMA INTERNATIONAL OPERATIONS UNLIMITED COMPANY (f/k/a Alexion Pharma International Trading), a company incorporated in Ireland with company registration number 528478 and having its registered office at College Business & Technology Park, Blanchardstown Road North, Dublin 15, Ireland (“APIO”) and certain Subsidiaries of the Administrative Borrower party hereto pursuant to Section 2.15 (collectively with APH and APIO, each a “Designated Borrower” and, together with the Administrative Borrower, the “Borrowers” and, each a “Borrower”), each lender from time to ti

CREDIT AGREEMENT Dated as of June 22, 2015 among ALEXION PHARMACEUTICALS, INC., as the Administrative Borrower, BANK OF AMERICA, N.A., as Administrative Agent, THE OTHER LENDERS PARTY HERETO, JPMORGAN CHASE BANK, N.A., as Syndication Agent...

Credit Agreement • June 23rd, 2015 • Alexion Pharmaceuticals Inc • Pharmaceutical preparations • New York

• Contract Type
  Credit Agreement
• Filed
  June 23rd, 2015
• Company
  Alexion Pharmaceuticals Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This CREDIT AGREEMENT (“Agreement”) is entered into as of June 22, 2015, among ALEXION PHARMACEUTICALS, INC., a Delaware corporation (the “Administrative Borrower”), ALEXION PHARMA HOLDING, a company incorporated in Ireland with company registration number 528477 and having its registered office at 25-28 North Wall Quay, Dublin 1 Ireland (“APH”), ALEXION PHARMA INTERNATIONAL TRADING, a company incorporated in Ireland with company registration number 528478 and having its registered office at 25-28 North Wall Quay, Dublin 1 Ireland (“APIT”) and certain Subsidiaries of the Administrative Borrower party hereto pursuant to Section 2.15 (collectively with APH and APIT, each a “Designated Borrower” and, together with the Administrative Borrower, the “Borrowers” and, each a “Borrower”); each lender from time to time party hereto (collectively, the “Lenders” and individually, a “Lender”), BANK OF AMERICA, N.A., as Administrative Agent, BANK OF AMERICA, N.A. (AN AFFILIATE OF MERRILL LYNCH, PIER